| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |